Search

Dilip J Gole

from Plainsboro, NJ
Age ~71
Get Report
Also known as:
Dilip G Gole, Dilip J Cole, Dulip J Gole
Phone and address:
4 Clydesdale Ct, Plainsboro, NJ 08536
(609) 275-8353
Related to:
Dave Mayankumar, 60Rahul D Gole, 37Suvarna D Gole, 68Abhishek D Gole, 40
Connected to:
Anand M Gole, 51Lisa A Gole, 64Monica Gole, 40Rickie G Gole, 71Thomas G Gole, 69Eugen C Golea, 55Julia A Golebiewski, 41Kamila Golebiewska, 38Michael Golebie, 32Emilia Golebiowska, 58

Dilip Gole Phones & Addresses

  • 4 Clydesdale Ct, Plainsboro, NJ 08536 (609) 275-8353
  • 3628 Wellington Cross Rd, Ann Arbor, MI 48105 (734) 662-8968
  • Savannah, GA
  • 4 Clydesdale Ct, Plainsboro, NJ 08536 (609) 713-9499

Work

Position: Medical Professional

Education

Degree: Graduate or professional degree

Emails

k***h@comcast.net

Professional Records

License Records

Dilip J Gole

Address:
Ann Arbor, MI 48105
License #:
5302029172 - Expired
Category:
Pharmacy
Issued Date:
Dec 28, 1992
Expiration Date:
Jun 30, 1993
Type:
Pharmacist - Ed Ltd

Medicine Doctors

Dilip Gole Photo 1

Dilip E. Gole

View page
Specialties:
Pediatric Radiology, Radiology
Work:
Nemours Children's Health SystemNemours Childrens Clinic
1717 S Orange Ave STE 100, Orlando, FL 32806
(407) 650-7000 (phone), (407) 650-7124 (fax)

Nemours Children's Health SystemNemours Childrens Specialty Clinic Of Jacksonville
807 Childrens Way, Jacksonville, FL 32207
(904) 697-3600 (phone), (904) 697-3432 (fax)

Wolfson Childrens Hospital Radiology
800 Prudential Dr FL 1, Jacksonville, FL 32207
(904) 202-8136 (phone), (904) 202-8109 (fax)

Nemours Children's Health SystemNemours Childrens Clinic Jacksonville South
14785 Old Saint Augustine Rd STE 200, Jacksonville, FL 32258
(904) 697-3600 (phone), (904) 697-3927 (fax)
Education:
Medical School
Grant Med Coll, Univ of Mumbai, Mumbai, Maharashtra, India
Graduated: 1973
Languages:
Arabic
English
Description:
Dr. Gole graduated from the Grant Med Coll, Univ of Mumbai, Mumbai, Maharashtra, India in 1973. He works in Jacksonville, FL and 3 other locations and specializes in Pediatric Radiology and Radiology. Dr. Gole is affiliated with Arnold Palmer Hospital For Children, Florida Hospital Orlando, Orlando Regional Medical Center and Wolfson Childrens Hospital.

Publications

Us Patents

Taste-Masked Resinate And Preparation Thereof

View page
US Patent:
20050036977, Feb 17, 2005
Filed:
Aug 11, 2003
Appl. No.:
10/638822
Inventors:
Dilip Gole - Plainsboro NJ, US
Traci Savall - San Diego CA, US
Dale Greenwood - Fishers IN, US
Paul Wilkinson - Titusville NJ, US
John Davies - Princeton NJ, US
International Classification:
A61L009/01
A61L009/00
US Classification:
424076100
Abstract:
The present invention is directed to a taste-masked resinate that contains a water-insoluble active substance complexed to an ion-exchange resin in a taste-masking effective amount. The taste-masked resinate is useful in the manufacture of a dosage form such as a rapid-disintegrating tablet, a rapid-disintegrating film, an effervescent tablet, a chewable tablet, a chewing gum, a suspension, a sprinkle granule, a powder for reconstitution in a suspension and the like and a method for the preparation thereof.

Controlled Release Composition

View page
US Patent:
20050074490, Apr 7, 2005
Filed:
Dec 23, 2003
Appl. No.:
10/744751
Inventors:
Shun Lin - Plainsboro NJ, US
Lorraine Wearley - Westfield NJ, US
Dilip Gole - Plainsboro NJ, US
Gary Posage - New Hope PA, US
Paul Wilkinson - Doylestown PA, US
International Classification:
A61K009/22
US Classification:
424468000
Abstract:
The present invention provides a composition comprising a sustained release layer and a fast release layer. The sustained release layer comprises a water-soluble polymer and a first pharmaceutically active agent. The fast release layer comprises a matrix forming agent and a second pharmaceutically active agent. Generally, the composition provides fast and sustained (or controlled) release of a pharmaceutically active agent for at least 6 hours and preferably for at least 1 to 3 days. The composition may be incorporated into a dosage unit form, such as a vaginal insert. Methods of preparing the composition are also provided.

Cephalosporin Derivative Formulation

View page
US Patent:
20080103121, May 1, 2008
Filed:
Oct 18, 2007
Appl. No.:
11/874405
Inventors:
Dilip Gole - Plainsboro NJ, US
Ketan Amin - Randolph NJ, US
M. llias Jimidar - Turnhout, BE
Hans Vermeersch - Gent, BE
Michael Tran - Cheltenham PA, US
International Classification:
A61K 31/546
A61P 31/04
US Classification:
514202000
Abstract:
The present invention relates to a freeze-dried formulation for cephalosporin derivatives having increased stability and a method for preparing such a formulation using certain excipients for stabilizing the formulation.

Pharmaceutical And Other Dosage Forms

View page
US Patent:
56480938, Jul 15, 1997
Filed:
May 22, 1995
Appl. No.:
8/447253
Inventors:
Dilip J. Gole - Ann Arbor MI
R. Saul Levinson - Chesterfield MO
Paul K. Wilkinson - Ann Arbor MI
J. Desmond Davies - Grosse Pointe Farms MI
Assignee:
Janssen Pharmaceutica Inc. - Piscataway NJ
International Classification:
A61K 914
US Classification:
424484
Abstract:
A fast dissolving, solid dosage form defined by a matrix containing gelatin, pectin and/or soy fiber protein and one or more amino acids having from about 2 to 12 carbon atoms is disclosed.

Pharmaceutical And Other Dosage Forms

View page
US Patent:
55588808, Sep 24, 1996
Filed:
Apr 28, 1994
Appl. No.:
8/234295
Inventors:
Dilip J. Gole - Ann Arbor MI
R. Saul Levinson - Chesterfield MO
Paul K. Wilkinson - Ann Arbor MI
J. Desmond Davies - Grosse Pointe Farms MI
Assignee:
Janssen Pharmaceutica Inc. - Piscataway NJ
International Classification:
A61K 914
US Classification:
424484
Abstract:
A fast dissolving, solid dosage form defined by a matrix containing gelatin, pectin and/or soy fiber protein and one or more amino acids having from about 2 to 12 carbon atoms is disclosed.

Preparation Of Pharmaceutical And Other Matrix Systems By Solid-State Dissolution

View page
US Patent:
52157563, Jun 1, 1993
Filed:
Nov 6, 1990
Appl. No.:
7/613087
Inventors:
Dilip J. Gole - Ann Arbor MI
R. Saul Levinson - Saline MI
James Carbone - Belleville MI
J. Desmond Davies - Grosse Pointe Farms MI
International Classification:
A61K 914
US Classification:
424484
Abstract:
A method is disclosed for preparing pharmaceutical and other matrix systems that comprises solidifying a matrix composition dissolved or dispersed in a first solvent and subsequently contacting the solidified matrix with a second solvent that is substantially miscible with the first solvent at a temperature lower than the solidification point of the first solvent, the matrix components being substantially insoluble in the second solvent, whereby the first solvent is substantially removed resulting in a usable matrix.

Methods Of Preparing Bulk Delivery Matrices By Solid-State Dissolution

View page
US Patent:
53307640, Jul 19, 1994
Filed:
Jul 23, 1991
Appl. No.:
7/734635
Inventors:
Dilip J. Gole - Ann Arbor MI
R. Saul Levinson - Saline MI
James Carbone - Belleville MI
J. Desmond Davies - Grosse Pointe Farms MI
Assignee:
Janssen Pharmaceutica Inc. - Piscataway NJ
International Classification:
A61K 914
US Classification:
424484
Abstract:
A method is disclosed for preparing pharmaceutical and other matrix systems that comprises solidifying a matrix composition dissolved or dispersed in a first solvent and subsequently contacting the solidified matrix with a second solvent that is substantially miscible with the first solvent at a temperature lower than the solidification point of the first solvent, the matrix components being substantially insoluble in the second solvent, whereby the first solvent is substantially removed resulting in a usable matrix.

Compositions Containing Ibrutinib

View page
US Patent:
20220211713, Jul 7, 2022
Filed:
Mar 29, 2022
Appl. No.:
17/706783
Inventors:
- Beerse, BE
Kaustubh Tambwekar - Mumbai, IN
Binuraj Krishnan Nair - Mumbai, IN
Dilip J. Gole - Plainsboro NJ, US
Maristella Bernini - Beerse, BE
Sabine Inghelbrecht - Stekene, BE
International Classification:
A61K 31/519
A61K 9/48
A61K 9/00
A61J 3/07
B01J 2/22
B01J 2/10
A61K 47/02
A61K 47/12
A61K 9/10
A61K 47/38
A23L 33/10
A23L 33/16
Abstract:
Discussed herein are pharmaceutical compositions containing Ibrutinib and processes for preparing them. The compositions may be utilized in the treatment of a variety of conditions including, without limitation, B-cell proliferative disorders such as non-Hodgkin lymphoma (diffuse large B cell lymphoma, follicular lymphoma, mantle cell lymphoma or burkitt lymphoma), Waldenstrom macroglobulinemia, plasma cell myeloma, chronic lymphocytic leukemia, lymphoma, or leukemia. These compositions are designed for oral ingestion. The compositions are contained within a capsule such as a standard or sprinkle or in a liquid formulation such as a suspension. In one embodiment, the pharmaceutical composition contains Ibrutinib, a salt, prodrug, or metabolite thereof, microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, and magnesium stearate. In another embodiment, the pharmaceutical composition contains Ibrutinib, a salt, prodrug, or metabolite thereof, microcrystalline cellulose, carboxymethylcellulose sodium, hydroxypropylmethylcellulose, citric acid monohydrate, disodium hydrogen phosphate, sucralose, sodium methyl parahydroxybenzoate, sodium ethyl parahydroxybenzoate, concentrated hydrochloric acid, sodium hydroxide, and water.
Control profile
Dilip J Gole from Plainsboro, NJ, age ~71 Get Report